Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 3:11 AM
Ignite Modification Date: 2025-12-26 @ 1:49 AM
NCT ID: NCT01355705
Description: None
Frequency Threshold: 5
Time Frame: Up to 12 weeks treatment, plus a minimum of 30 days follow-up
Study: NCT01355705
Study Brief: Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Amrubicin + Lenalidomide + Dexamethasone Amrubicin 40, 60, or 80 mg/m2 intravenous (IV) will be given intravenously on Day 1 of each 3-week cycle beginning with 40 mg/m2, for a maximum of 4 cycles. Concurrent therapeutic medications: * Lenalidomide: 10 or 15 mg daily by mouth, Days 1 to 14 * Dexamethasone: 40 mg weekly by mouth (Days 1, 8, and 15) Other drugs: * Aspirin: 81 or 325 mg daily oral * Pegfilgrastim subcutaneous on Day 2 None None 3 14 12 14 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Sepsis SYSTEMATIC_ASSESSMENT Infections and infestations None View
Cord compression SYSTEMATIC_ASSESSMENT Nervous system disorders None View
Progressive disease SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Thrombocytopenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTCAE v4.0 View
Deep venous thrombosis SYSTEMATIC_ASSESSMENT Vascular disorders CTCAE v4.0 View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v4.0 View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v4.0 View
Diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v4.0 View
Constipation SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v4.0 View
Abdominal pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v4.0 View
Elevated AST/ALT SYSTEMATIC_ASSESSMENT Investigations CTCAE v4.0 View
Hypoalbuminemia SYSTEMATIC_ASSESSMENT Investigations CTCAE v4.0 View
Insomnia SYSTEMATIC_ASSESSMENT General disorders CTCAE v4.0 View
Dysgeusia SYSTEMATIC_ASSESSMENT General disorders CTCAE v4.0 View
Headache SYSTEMATIC_ASSESSMENT General disorders CTCAE v4.0 View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE v4.0 View
Bone pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE v4.0 View
Osteonecrosis SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE v4.0 View
Muscle weakness SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE v4.0 View
Muscle cramps SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE v4.0 View
Alopecia SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE v4.0 View
Dyspnea SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE v4.0 View
Hiccups SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE v4.0 View
Hypokalemia SYSTEMATIC_ASSESSMENT Investigations CTCAE v4.0 View
Fatigue SYSTEMATIC_ASSESSMENT General disorders CTCAE v4.0 View
Decreased ejection fraction (transient) SYSTEMATIC_ASSESSMENT Cardiac disorders CTCAE v4.0 View
Anemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTCAE v4.0 View
Neutropenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTCAE v4.0 View
Anorexia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE v4.0 View
Infection SYSTEMATIC_ASSESSMENT Infections and infestations CTCAE v4.0 View
Graft vs host diseae (GvHD) SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE v4.0 View
Skin disorder SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE v4.0 View
Creatinine SYSTEMATIC_ASSESSMENT Investigations CTCAE v4.0 View